{"transactions":[{"id":763822,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44236,"kind":"person","name":"CURHAN GREGORY S","position":1,"cik":"0001263244","reported_name":"CURHAN GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-05-26T23:35:30.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":123019,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Unless otherwise terminated as provided in the optionee's option agreement, 12/48ths of the shares subject to the option shall vest twelve months after the Vesting Commencement Date, and 1/48th of the shares subject to the option shall vest on the same calendar day of each subsequent month thereafter until the shares subject to the option are fully vested."}],"balance_after":123019,"derivative":{"exercise_price":1.89,"expiration_date":"2036-05-21","underlying":"Common Stock","underlying_shares":123019},"source":{"system":"sec-edgar","filing":"0001263244-26-000002","document":"wk-form4_1779838527.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000126324426000002/wk-form4_1779838527.xml","form_type":"4"}},{"id":1427677,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44236,"kind":"person","name":"CURHAN GREGORY S","position":1,"cik":"0001263244","reported_name":"CURHAN GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-08-21T01:01:14.000Z","date":"2024-08-15","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest in substantially equal monthly installments beginning on September 15, 2024 such that the stock options shall be fully vested on the fourth anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":250000,"derivative":{"exercise_price":6.66,"expiration_date":"2024-08-15","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001493152-24-033344","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000149315224033344/ownership.xml","form_type":"4"}},{"id":2349976,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":44236,"kind":"person","name":"CURHAN GREGORY S","position":1,"cik":"0001263244","reported_name":"CURHAN GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-04T21:20:24.000Z","date":"2022-03-02","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The total number of options vest in forty-eight (48) successive and equal monthly installments as measured from March 3, 2022 (the \"Vesting Commencement Date\"), such that 100% of the options will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":100000,"derivative":{"exercise_price":1.99,"expiration_date":"2032-03-01","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001601485-22-000011","document":"wf-form4_164642880552681.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263244/000160148522000011/wf-form4_164642880552681.xml","form_type":"4"}},{"id":2469655,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":44236,"kind":"person","name":"CURHAN GREGORY S","position":1,"cik":"0001263244","reported_name":"CURHAN GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-12-16T21:58:02.000Z","date":"2021-12-15","kind":"purchase","acquired":true,"shares":4000,"price":2.37,"value":9480.0,"ownership":{"direct":true},"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001601485-21-000085","document":"wf-form4_163969186318750.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263244/000160148521000085/wf-form4_163969186318750.xml","form_type":"4"}}]}